HIF1A and neoplasm: Hypoxia-inducible factor 1 alpha (HIF-1α) stands as a pivotal transcription factor in cancer progression and targeted therapies, closely linked to tumor metastasis, angiogenesis, poor patient prognosis, and resistance to cancer treatments (69, 70).